Komori
Alfresa Holdings (2784) · FactFirst stated

FY2018 Q2: Higher Revenue and Profit in the Pharmaceuticals and Other Products Manufacturing Business

First written in FY2018-Q2. . Latest entry: FY2018-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Higher revenue and profit in the pharmaceuticals and related products manufacturing businessA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2018-Q2First statedAnnual report

    「当第２四半期連結累計期間の業績は、売上高208億4百万円（前年同期比8.9％増）、営業利益15億44百万円（同200.4％増）となりました。」

    医薬品等製造事業は増収となり、営業利益は前年同期比200.4％増となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.